The Impact of Repeated Rounds of Mass Drug Administration with Diethylcarbamazine Plus Albendazole on Bancroftian Filariasis in Papua New Guinea

被引:68
|
作者
Weil, Gary J. [1 ]
Kastens, Will [2 ]
Susapu, Melinda [3 ]
Laney, Sandra J. [4 ]
Williams, Steven A. [4 ]
King, Christopher L. [2 ]
Kazura, James W. [2 ]
Bockarie, Moses J. [2 ,3 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO 63130 USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[3] Papua New Guinea Inst Med Res, Madang, Papua N Guinea
[4] Smith Coll, Northampton, MA 01063 USA
来源
PLOS NEGLECTED TROPICAL DISEASES | 2008年 / 2卷 / 12期
关键词
D O I
10.1371/journal.pntd.0000344
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: This study employed various monitoring methods to assess the impact of repeated rounds of mass drug administration (MDA) on bancroftian filariasis in Papua New Guinea, which has the largest filariasis problem in the Pacific region. Methodology/Principal Findings: Residents of rural villages near Madang were studied prior to and one year after each of three rounds of MDA with diethylcarbamazine plus albendazole administered per World Health Organization (WHO) guidelines. The mean MDA compliance rate was 72.9%. Three rounds of MDA decreased microfilaremia rates (Mf, 1 ml night blood by filter) from 18.6% pre-MDA to 1.3% after the third MDA (a 94% decrease). Mf clearance rates in infected persons were 71%, 90.7%, and 98.1% after 1, 2, and 3 rounds of MDA. Rates of filarial antigenemia assessed by card test (a marker for adult worm infection) decreased from 47.5% to 17.1% (a 64% decrease) after 3 rounds of MDA. The filarial antibody rate (IgG(4) antibodies to Bm14, an indicator of filarial infection status and/or exposure to mosquito-borne infective larvae) decreased from 59.3% to 25.1% (a 54.6% decrease). Mf, antigen, and antibody rates decreased more rapidly in children,11 years of age (by 100%, 84.2%, and 76.8%, respectively) relative to older individuals, perhaps reflecting their lighter infections and shorter durations of exposure/infection prior to MDA. Incidence rates for microfilaremia, filarial antigenemia, and antifilarial antibodies also decreased significantly after MDA. Filarial DNA rates in Anopheles punctulatus mosquitoes that had recently taken a blood meal decreased from 15.1% to 1.0% (a 92.3% decrease). Conclusions/Significance: MDA had dramatic effects on all filariasis parameters in the study area and also reduced incidence rates. Follow-up studies will be needed to determine whether residual infection rates in residents of these villages are sufficient to support sustained transmission by the An. punctulatus vector. Lymphatic filariasis elimination should be feasible in Papua New Guinea if MDA can be effectively delivered to endemic populations.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] The impact of mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt
    Elaziz, Khaled M. Abd
    EI-Setouhy, Maged
    Helmy, Hanan
    Ramzy, Reda M. R.
    Weil, Gary J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 94 - 94
  • [2] Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial
    Laman, Moses
    Tavul, Livingstone
    Karl, Stephan
    Kotty, Bethuel
    Kerry, Zebede
    Kumai, Stephen
    Samuel, Anna
    Lorry, Lina
    Timinao, Lincoln
    Howard, S. Cade
    Makita, Leo
    John, Lucy
    Bieb, Sibauk
    Wangi, James
    Albert, Jeffrey M.
    Payne, Michael
    Weil, Gary J.
    Tisch, Daniel J.
    Bjerum, Catherine M.
    Robinson, Leanne J.
    King, Christopher L.
    LANCET INFECTIOUS DISEASES, 2022, 22 (08): : 1200 - 1209
  • [3] Impact of mass drug administration with ivermectin, diethylcarbamazine, and albendazole for lymphatic filariasis on hookworm and Strongyloides stercoralis infections in Papua New Guinea
    Ramos, Jannet A. Tobon
    Maure, Tobias
    Carias, Lenore
    Lew, Daphne
    Goss, Charles
    Samuel, Anna
    Tavul, Livingstone
    Fischer, Peter U.
    Weil, Gary J.
    Laman, Moses
    Robinson, Leanne J.
    Pomat, William
    King, Christopher L.
    PLOS NEGLECTED TROPICAL DISEASES, 2025, 19 (03):
  • [4] COMMUNITY-LEVEL EFFECTIVENESS OF MASS DRUG ADMINISTRATION OF IVERMECTIN, DIETHYLCARBAMAZINE AND ALBENDAZOLE VERSUS DIETHYLCARBAMAZINE AND ALBENDAZOLE FOR ELIMINATION OF LYMPHATIC FILARIASIS IN PAPUA NEW GUINEA
    Laman, Moses
    Tavul, Livingstone
    Karl, Stephan
    Kotty, Bethuel
    Kerry, Zebedee
    Kumai, Steven
    Samuel, Anna
    Lorry, Lina
    Timinao, Lincoln
    Howard, Samuel C.
    Wangi, James
    Makita, Leo
    John, Lucy
    Bieb, Sibauk
    Goss, Charles W.
    O'Brian, Katiuscia
    Weil, Gary J.
    Kazura, James W.
    Tisch, Daniel J.
    Bjerum, Catherine
    King, Christopher L.
    Robinson, Leanne J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 199 - 199
  • [5] Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment
    Ramzy, RMR
    El Setouhy, M
    Helmy, H
    Ahmed, ES
    Abd Elaziz, KM
    Farid, HA
    Shannon, WD
    Weil, GJ
    LANCET, 2006, 367 (9515): : 992 - 999
  • [6] Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis
    Chhonker, Yashpal S.
    Bjerum, Catherine
    Bala, Veenu
    Ouattara, Allassane F.
    Koudou, Benjamin G.
    Gabo, Toki P.
    Alshehri, Abdullah
    Meite, Abdoulaye
    Fischer, Peter U.
    Weil, Gary J.
    King, Christopher L.
    Budge, Philip J.
    Murry, Daryl J.
    PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (08):
  • [7] THE IMPACT OF MASS DRUG ADMINISTRATION WITH A TRIPLE DRUG REGIMEN (IVERMECTIN, DIETHYLCARBAMAZINE AND ALBENDAZOLE) ON LYMPHATIC FILARIASIS IN PAPUA NEW GUINEA AND IMPLICATIONS FOR POST-MDA SURVEILLANCE
    Bun, Krufinta
    Laman, Moses
    Susapu, Melinda
    Sekihara, Makoto
    Giorgi, Emanuele
    Diggle, Peter J.
    Payne, Michael
    Tisch, Daniel
    Bjerum, Catherine
    Mode, Benedict
    Robinson, Leanne
    Weil, Gary
    King, Christopher L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 138 - 138
  • [8] IMPACT OF ONCE VERSUS TWICE PER YEAR MASS DRUG ADMINISTRATION WITH DIETHYLCARBAMAZINE PLUS ALBENDAZOLE FOR LYMPHATIC FILARIASIS ON HOOKWORM PREVALENCE AND HEMOGLOBIN LEVELS IN PAPUA NEW GUINEA (PNG)
    Mancuso, Brooke
    Sanuku, Nelly
    Satofan, Samson
    Beaso, Delma
    Cheng, Yao-Chieh
    Muare, Tobias
    Pomat, William
    Majewski, Andrew
    Kazura, James
    Weil, Gary J.
    Fischer, Peter U.
    King, Christopher L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 618 - 618
  • [9] ANNUAL VERSUS SEMI-ANNUAL MASS DRUG ADMINISTRATION WITH DIETHYLCARBAMAZINE PLUS ALBENDAZOLE FOR ELIMINATION OF LYMPHATIC FILARIASIS IN EAST SEPIK PROVINCE, PAPUA NEW GUINEA
    Payne, Michael C.
    Lus, Philip
    Sanuku, Nelly
    Mancuso, Brooke
    Suamani, James
    Beaso, Delma
    Weil, Gary J.
    Fischer, Peter U.
    Laman, Moses
    Robinson, Leanne J.
    Tisch, Daniel J.
    King, Christopher L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 26 - 26
  • [10] DEC alone versus dec plus albendazole for control of bancroftian filariasis in papua new guinea
    Bockarie, Moses J.
    Tavul, Livingstone
    Kastens, Will
    Tisch, Daniel J.
    Kazura, James W.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 360 - 360